PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Go Deep

Precision BioSciences, Inc.

Precision BioSciences, Inc. Score & Ratio Trend

DateScoreP/EP/BD/EPrice
Sep 2026 22,274 -4.9 3.79 0.62 6.50
Sep 2026 22,417 -4.4 3.71 0.62 6.36
Sep 2026 22,560 -4.7 3.63 0.62 596.70
Oct 2026 18,264 -4.7 3.85 0.62 606.88
Oct 2026 18,264 -4.7 3.85 0.62 606.88
Oct 2026 18,264 -4.7 3.85 0.62 606.88
Oct 2026 18,105 -4.6 3.78 0.62 597.79
Oct 2026 18,105 -4.7 3.78 0.62 597.79
Oct 2026 18,064 -4.6 3.81 0.62 603.35
Oct 2026 17,915 -4.8 3.92 0.62 620.73
Oct 2026 17,926 -5.0 4.09 0.62 650.20
Oct 2026 18,003 -4.8 3.98 0.62 625.19
Oct 2026 18,668 -4.5 3.72 0.62 580.93
Oct 2026 18,725 -4.5 3.67 0.62 572.53
Oct 2026 18,610 -4.6 3.76 0.62 585.91
Oct 2026 18,940 -4.3 3.52 0.62 546.51
Oct 2026 18,593 -4.6 3.77 0.62 586.91
Oct 2026 18,288 -4.9 4.00 0.62 622.00
Oct 2026 18,164 -5.0 4.09 0.62 634.65
Oct 2026 18,106 -5.0 4.13 0.62 639.97
Oct 2026 18,222 -4.9 4.05 0.62 629.35

Precision BioSciences, Inc. Quarterly Results

Line Item Jun 2026Mar 2026Dec 2025Sep 2025
Revenue 0.0 10,838,000.0 34,204,000.0 13,000.0
Net Profit -32,652,000.0 -18,441,000.0 20,133,000.0 -21,772,000.0
EPS -1.3 -0.8 1.1 -1.8

Precision BioSciences, Inc. Revenue & Profit: Last 5 Years

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Revenue 34,264,000.0 68,696,000.0 48,727,000.0 25,098,000.0 —
Net Profit -45,724,000.0 7,167,000.0 -61,319,000.0 -111,637,000.0 —
EPS -3.6 1.1 -16.0 -38.1 —

Precision BioSciences, Inc. Balance Sheet

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Total Assets 154,416,000.0 136,388,000.0 159,781,000.0 238,169,000.0 —
Total Liabilities 62,168,000.0 79,995,000.0 140,920,000.0 177,736,000.0 —
Total Equity 92,248,000.0 56,393,000.0 18,861,000.0 60,433,000.0 —

Owes vs Owns

Precision BioSciences, Inc. owed $0.64 for every $1 it owned in Jun 2026, down from $0.75 in Dec 2022.

PeriodJun 2026Dec 2025Dec 2024Dec 2023Dec 2022
Owes vs Owns 0.64× 0.40× 0.59× 0.88× 0.75×

Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.

Precision BioSciences, Inc. Assets & Liabilities Breakdown (USD millions)

What it owns — Dec 2025

Cash & short-term investments 74.9%Fixed assets (tangible) 4.7%Intangible assets 0.8%Other assets 19.2%

How it's funded — Dec 2025

Short-term debt 1.0%Long-term debt 14.5%Other liabilities 24.6%Shareholders' equity 59.7%
Line Item Dec 2025Dec 2024Dec 2023Dec 2022
Assets
Cash & short-term investments115.686.3116.7189.6
Receivables0.01.712.80.7
Inventory0.00.00.00.0
Fixed assets (tangible)7.210.214.613.8
Intangible assets1.20.60.40.7
Long-term investments0.73.23.24.7
Other assets29.734.412.128.6
Liabilities & equity
Short-term debt1.51.322.41.7
Long-term debt22.422.37.722.2
Payables0.31.33.00.7
Other liabilities38.055.0107.8153.2
Shareholders' equity92.256.418.960.4
Net tangible assets91.155.818.559.7

Precision BioSciences, Inc. Cash Flow

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Operating Activities -65,843,000.0 -58,445,000.0 -84,114,000.0 -45,753,000.0 —
Investing Activities -634,000.0 -215,000.0 5,829,000.0 -3,319,000.0 —
Financing Activities 95,162,000.0 50,450,000.0 5,387,000.0 94,985,000.0 —

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.